Daily acetaminophen cuts risk of prostate cancer by 38%, study finds

05/26/2011 | HealthNews.com

A study in Cancer Epidemiology, Biomarkers and Prevention found that men who took a single tablet of acetaminophen daily for at least five years reduced their risk of prostate cancer by 38% and were less likely to develop the cancer's aggressive form. In a separate study, published in Cancer Research, prostate cancer patients who engaged in brisk walking three or more hours weekly had a 57% reduction in the risk for disease progression.

View Full Article in:

HealthNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA